Jiangsu Aidea Pharmaceutical Co.,Ltd., set up in Year 2009, is located in Yangzhou, Jiangsu Province. With support of the government and efforts of our employees, now Aidea has not only become the famous human sources products production base, and become one of the outstanding domestic enterprises in innovation drug research and development.
In the early days of its development, Aidea successfully developed the world’s first online human urine protein adsorption technology, using highly efficient resin to develop a set of effective process flow and achieve online and efficient adsorption of urinary proteins like Urinary Trypsin Inhibitor (UTI), Urokinase (UK), and Human Urinary Kallidinogenase (KN). Collecting urinary proteins instead of urine avoids influence on environment and greatly expands the source of urinary protein raw materials.Now, Aidea is a large producer and supplier of global UTI raw materials.
In order to develop innovative drug, Aidea introduced overseas high-level talents to focus on development of new chemical entities of anti-tumor, anti-virus and cardiovascular areas,among which two NCE drugs for the treatment of Cancer and AIDS have been approved by CFDA for clinical trials.